Clinical Trial Highlights

• Carbohydrate Counting Does Not Improve Glycemic Control in Type 1 Diabetes Patients
• Lifestyle Intervention is Beneficial in Pregnant Women at Risk for Gestational Diabetes
• Participation in VA's MOVE! Associated with Weight Loss
• Neurocognitive Decline Unrelated to Mild Cognitive Impairment in Type 1 Diabetes
• Metformin/Pioglitazone/Exenatide Triple Therapy Superior to Stepwise Add-On Conventional Therapy in Newly Diagnosed Type 2 Diabetes
• Insulin Dose Not Linked to Cardiovascular Mortality in the ACCORD Trial
• Canagliflozin Reduces HbA1C in Patients with Stage 3 CKD, with the Change Greater in Patients with Higher eGFR
• Education Improves Hypoglycemia Awareness Regardless of Technology Used for Insulin Delivery
• Cardiovascular Safety of Linagliptin in Patients with Type 2 Diabetes
• DURATION-3 Trial Results
• Empagliflozin Improves Glycemic Parameters and Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus